Physician profile
Michael Stiefel
NPI 1427111681
$101,727.57
in general payments reported to CMS, 2019-2025
17 companies · $35K in 2025
The $35K reported for 2025 was more than what 93% of Neurological Surgery providers received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $500 · 2020: $1,900 · 2021: $45.55 · 2022: $28K · 2023: $26K · 2024: $10K · 2025: $35K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $61K · Travel and Lodging: $4,904 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $4,500 · Food and Beverage: $1,051.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $61,025.00 |
| Travel and Lodging | $4,904.44 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $4,500.00 |
| Food and Beverage | $1,050.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $68,679.32 | 2022-2025 | Surpass Evolve, Axs Vecta 71, Synchro Select |
| Medtronic, INC. | $8,834.91 | 2022-2024 | Pipeline, Solitaire X, Onyx 18 |
| Cordis US Corp. | $7,226.56 | 2025 | Mynx Control Venous, Angioguard, Selution Slr Ptca |
| Viz.Ai, INC. | $6,387.50 | 2022 | |
| Qapel Medical INC | $5,000.00 | 2024-2025 | |
| Medtronic USA, INC. | $2,400.00 | 2019-2020 | |
| Imperative Care, INC | $1,425.00 | 2023 | Zoom 88-T Large Distal Platform |
| Medical Device Business Services, INC. | $1,350.00 | 2022 | |
| Penumbra, INC. | $152.87 | 2025 | Indigo System, Red 72, Penumbra System |
| Depuy Synthes Sales INC. | $114.71 | 2021-2022 | |
| Balt USA, LLC | $73.70 | 2024 | Prestige Coil System, Optima Coil System |
| Edwards Lifesciences Corporation | $32.61 | 2024 | Hemosphere |
| Alnylam Pharmaceuticals INC. | $21.67 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $15.26 | 2022 | |
| Philips North America LLC | $13.46 | 2022 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Stiefel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.